BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

OptiNose AS 

Oslo Innovation Center
Gaustadalléen 21
Oslo    N-0349  Norway
Phone: 47-2295-8014 Fax: 47-2295-8098


SEARCH JOBS


Industry
Medical Device






 Company News
OptiNose AS Announces FDA Acceptance Of New Drug Application For AVP-825 For The Acute Treatment Of Migraine 3/27/2014 9:21:30 AM    More...
OptiNose AS to Present Data Highlighting New Migraine Treatment at International Headache Congress 6/28/2013 9:24:11 AM    More...
OptiNose AS Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device 2/9/2012 7:48:40 AM    More...
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology 2/3/2012 6:15:20 AM    More...
OptiNose AS Selects BioClinica, Inc.'s Trident IWR, Optimizer and Imaging Core Lab Solutions 9/8/2011 10:00:56 AM    More...
OptiNose AS Standardizes on Medidata Solutions, Inc. Rave Clinical Technology 8/30/2011 10:44:43 AM    More...
OptiNose AS Bi-Directional Drug Delivery Technology Wins Innovation Award for Potential Benefits of Nose to Brain Application 5/23/2011 11:07:18 AM    More...
OptiNose AS Receives Nearly $489,000 Grant Award under U.S. Government Qualifying Therapeutic Discovery Project Program 11/3/2010 11:43:30 AM    More...
Rapid Absorption Rate Alone May Not Explain Efficacy in Migraines of Sumatriptan Delivered with OptiNose AS's Novel Drug Delivery Technology 10/28/2010 12:10:09 PM    More...
OptiNose AS Announces Publication of Positive Subgroup Analysis Evaluating Efficacy of Fluticasone Delivered with Novel Drug Delivery Technology 8/10/2010 9:21:59 AM    More...
12

//-->